A phase II study of C019199 in combination with sintilimab in patients with locally recurrent or metastatic triple negative breast cancer (TNBC).

Authors: Yongchang Zhang, Feng Ye, Jian Liu, Zhenhua Liu, Zhiyong Chen, Xiang Li

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e13134

Source: Full article

---

Abstract

e13134